On the other hand, oral supplementation of non-responder patients with A. muciniphila upon FMT restored the anti-PDCD1 efficacy via IL12 by increasing the recruitment and infiltration of CXCR3+, CCR9+, CD4+ T cells into the mouse tumor site (193). The gene discussed is PDCD1; the disease is neoplasm.